P.O. Box 110287
Research Triangle Park
About Pappas VenturesPappas Ventures is a Research Triangle Park, North Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has over $350 million under management, and is currently investing out of its fourthventure capital fund. Among the firm’s more than 40 portfolio companies are FlowCardia, LipoScience, Plexxikon, BrainCells, CeNeRx BioPharma , CoLucid Pharmaceuticals, and TyRx. The firm's primary investment focus is on product-oriented biotechnology and pharmaceutical companies, with a secondary focus on medical technologies.
4 articles with Pappas Ventures
Pappas Capital Expands Leadership Team With Appointments Of Kyle Rasbach To Managing Partner And Matthew Boyer To Chief Financial Officer
Positions Firm for Next Phase of Growth and Development Following Successful 25-Year Track Record
4D Molecular Therapeutics snagged $90 million in a Series B financing round. The company intends to use the funds to advance its Therapeutic Vector Evolution platform and pipeline of next-generation AAV gene therapeutics.